Thursday, 21 December 2017

FDA approves La Jolla's low blood pressure drug

(Reuters) - La Jolla Pharmaceutical said on Thursday the U.S. Food and Drug Administration had approved its drug, Giapreza, to treat dangerously low blood pressure.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)